Somaí publishes a technical article with the University of Lusófona. The IG Hanf (Hemp Association) welcomes the progress of cannabis legalization in Switzerland. Bloomwell warns against restrictions on telemedicine. Grünhorn launches a petition and points to rapid market developments. Cantourage significantly increases sales. Synbiotic plans to focus on medical cannabis and hemp. Updates from the clubs. Demecan increases sales. Canify expands its product portfolio. The industry update in brief.
Somaí and Lusófona University publish specialist publication
Somaí, in collaboration with Lusófona University – the largest private university in Portugal and the main institution of Grupo Lusófona – has published a peer-reviewed paper in the journal Pharmaceuticals entitled “Process Development for GMP-Compliant Full-Spectrum Cannabis Oil: Towards Standardized Medical Use.”
IG Hanf: Switzerland loses one billion francs to the illegal market
According to the IG Hanf (German Hemp Association), Switzerland loses almost one billion Swiss francs to criminals every year through the illegal cannabis market. Now, according to the IG Hanf (German Hemp Association), a draft law for the regulation of cannabis is finally being drafted. Only a bold, realistic approach can dry up the black market and protect consumers, the interest group demands in a press release. On Friday, July 4, 2025, the National Council’s Health Committee approved the preliminary draft and explanatory report for consultation in implementation of Siegenthaler’s parliamentary initiative, “Regulation of the Cannabis Market for Better Youth and Consumer Protection” (20,473). The consultation will open at the end of August. Furthermore, the committee has requested a two-year extension of the initiative so that work on the law can progress.
4 Strains Social Club: Cultivation started
The cannabis cultivation association 4 Strains Social Club e. V., licensed by the Lower Saxony Chamber of Agriculture, has reportedly begun legal cannabis cultivation and expects to distribute the first strains in Braunschweig in August 2025.
Grünhorn: Rapid development of the medical cannabis market
According to Grünhorn, the market for medical cannabis in Germany has developed rapidly since the Medical Cannabis Act came into force in April 2024. In addition to an improved supply situation, current data from the Grünhorn Group now shows that a structural oversupply is changing the economic rules of the supply market. Import volumes have risen from 32 tons (2023) to 72 tons (2024) – an increase of more than 120 percent. At the same time, the number of specialized cannabis pharmacies has quintupled from around 50 in April 2024 to over 250 a year later. Average dispensing prices have fallen from €9.98 to €9.06 per gram over the same period, a decrease of almost ten percent. In June 2025, the average price will be €8.77.
Grünhorn: Petition launched
In response to the draft bill from Federal Health Minister Nina Warken (CDU), Grünhorn launched the online petition “Cannabis is Medicine – Stop the Ban, Protect Patients!” The petition opposes the planned ban on telemedical prescriptions of cannabis with subsequent delivery and will be officially submitted to the German Bundestag once it has received 50,000 votes.
Bloomwell: Restrictions on cannabis telemedicine strengthen the illegal market
Restricting low-threshold telemedical access to cannabis therapy would have drastic consequences for patients in Germany. According to Bloomwell, in a recent survey of more than 2,500 patients, over 40 percent stated that they would return to the illegal market if this were to happen.
Synbiotic: Focus on medical cannabis and industrial hemp
Synbiotic, the European medical cannabis and industrial hemp group, says it will focus even more on the medical cannabis and industrial hemp markets in the future. According to the press release, Synbiotic expects consolidated sales of approximately EUR 26 million for the 2025 fiscal year. The company aims to achieve positive EBITDA by the first half of 2026 at the latest.
Cantourage: Increase in sales
According to the Cantourage Group, the second quarter of 2025 saw the strongest quarter in the company’s history, with sales of €27.9 million. This brings sales in 2025 to €54 million at the midpoint of the year, exceeding the previous year’s total annual sales (€51.4 million).
Cantourage: Patrick Hoffmann succeeds Philip Schetter
According to a statement from Cantourage, Philip Schetter is unable to perform his duties as a member of the Management Board for personal reasons until further notice. The Supervisory Board has therefore appointed Patrick Hoffmann as deputy member of the Management Board, effective immediately until December 31, 2025.
Green Mile Social: First cultivation association licensed in Duisburg
The Düsseldorf district government has granted the cultivation association Green Mile Social Club eV the necessary licenses to cultivate and distribute cannabis. According to the company, this makes Green Mile the first publicly known, fully licensed cannabis cultivation association in Duisburg. The club plans to begin distributing cannabis to its members in Duisburg-Rheinhausen before the end of the year.
Demecan increases sales and increases cultivation capacity
Demecan more than doubled its sales in the first half of 2025 compared to the same period last year. With growth of 121 percent, revenue is already almost at the level of the full year 2024, according to the group. Furthermore, the group has increased its profitability and achieved a positive result for the period. Since mid-2024, DEMECAN has increased its workforce by almost 50 percent. Starting in August 2025, the group announces that it will expand its cultivation capacity at its production facility in Ebersbach, Saxony, from the current level of around two tons to over four tons annually.
Canify expands product portfolio
According to its own announcement, Canify is once again expanding its portfolio of dried cannabis flowers: In the new categories “Craft” and “Ghostdrops,” pharmacies will in the future find hand-picked flowers that are distinguished by special breeding characteristics and quality, the company promises.
Continue at: https://krautinvest.de/branchenupdate-mit-somai-ig-hanf-gruenhorn-bloomwell-synbiotic/
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link
Also see:
Manostaxx – Industrial Management Consulting
